<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Childhood B-cell <z:hpo ids='HP_0002664'>neoplasms</z:hpo> account for approximately 2% of childhood <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (ALL) </plain></SENT>
<SENT sid="1" pm="."><plain>The short but intensive chemotherapy yields a currently 75% to 85% event-free survival </plain></SENT>
<SENT sid="2" pm="."><plain>The prognosis for children with <z:e sem="disease" ids="C0277556" disease_type="Disease or Syndrome" abbrv="">relapsed disease</z:e> is considered to be dismal </plain></SENT>
<SENT sid="3" pm="."><plain>We report a 12-year old boy diagnosed with B-cell ALL with central <z:mp ids='MP_0008912'>nervous</z:mp> system (<z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi>) involvement </plain></SENT>
<SENT sid="4" pm="."><plain>He relapsed in the bone marrow immediately after primary chemotherapy </plain></SENT>
<SENT sid="5" pm="."><plain>Rituximab as a single agent achieved a complete morphologic remission </plain></SENT>
<SENT sid="6" pm="."><plain>After 4 treatments with rituximab an isolated <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> relapse occurred </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> remission was reinduced with chemotherapy and the patient received an autologous transplant with rituximab for in vivo purging </plain></SENT>
<SENT sid="8" pm="."><plain>He is currently in complete clinical and molecular remission for more than 1 year </plain></SENT>
</text></document>